• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟芬那酸药物共晶体:两种新型药物-药物共晶体的合成与表征

Pharmaceutical Co-Crystal of Flufenamic Acid: Synthesis and Characterization of Two Novel Drug-Drug Co-Crystal.

作者信息

Nechipadappu Sunil Kumar, Tekuri Venkatadri, Trivedi Darshak R

机构信息

Department of Chemistry, Supramolecular Chemistry Laboratory, National Institute of Technology, Karnataka (NITK), Srinivas Nagar, Surathkal, Mangaluru, Karnataka 575025, India.

Department of Chemistry, Supramolecular Chemistry Laboratory, National Institute of Technology, Karnataka (NITK), Srinivas Nagar, Surathkal, Mangaluru, Karnataka 575025, India.

出版信息

J Pharm Sci. 2017 May;106(5):1384-1390. doi: 10.1016/j.xphs.2017.01.033. Epub 2017 Feb 7.

DOI:10.1016/j.xphs.2017.01.033
PMID:28185907
Abstract

Two novel pharmaceutical co-crystals of anti-inflammatory drug flufenamic acid (FFA) with 2-chloro-4-nitrobenzoic acid (CNB) and ethenzamide (ETZ) have been synthesized by solvent evaporation method as well as by solvent drop-assisted grinding method. The synthesized co-crystals were characterized thoroughly by various spectroscopic methods and crystal structures were determined by single-crystal x-ray diffraction technique. In FFA-CNB co-crystal, robust supramolecular acid-acid homosynthon was observed. FFA-ETZ co-crystal is formed via robust supramolecular acid-amide heterosynthon. In FTIR spectra, a significant shift in the carbonyl stretching frequency was observed for the co-crystals due to the presence of intermolecular hydrogen bond. H nuclear magnetic resonance study suggests the presence of hydrogen bond in the solution state of FFA-ETZ co-crystal; however, it was absent for FFA-CNB co-crystal. Solubility study in Millipore water revealed that the solubility of FFA is increased by 2-fold when it is in the form of FFA-CNB co-crystal and no increment in the solubility of FFA was observed in FFA-ETZ co-crystal. About 5-fold increment in the solubility of FFA was observed in both the co-crystals in 0.1 N HCl (pH 1) solution. The synthesized co-crystals were found to be non-hygroscopic at ∼75% relative humidity and stable for a period of 6 months at ambient temperature (∼25°C).

摘要

通过溶剂蒸发法以及溶剂滴加辅助研磨法合成了抗炎药物氟芬那酸(FFA)与2-氯-4-硝基苯甲酸(CNB)和乙磺酰胺(ETZ)的两种新型药物共晶体。通过各种光谱方法对合成的共晶体进行了全面表征,并通过单晶X射线衍射技术确定了晶体结构。在FFA-CNB共晶体中,观察到了强大的超分子酸酸同合成子。FFA-ETZ共晶体是通过强大的超分子酸-酰胺异合成子形成的。在傅里叶变换红外光谱中,由于分子间氢键的存在,共晶体的羰基伸缩频率发生了显著位移。氢核磁共振研究表明,FFA-ETZ共晶体在溶液状态下存在氢键;然而,FFA-CNB共晶体中不存在氢键。在微孔水中的溶解度研究表明,FFA以FFA-CNB共晶体形式存在时,其溶解度增加了2倍,而在FFA-ETZ共晶体中未观察到FFA溶解度的增加。在0.1 N HCl(pH 1)溶液中,两种共晶体中FFA的溶解度均增加了约5倍。发现合成的共晶体在相对湿度约75%时不吸湿,在室温(约25°C)下可稳定6个月。

相似文献

1
Pharmaceutical Co-Crystal of Flufenamic Acid: Synthesis and Characterization of Two Novel Drug-Drug Co-Crystal.氟芬那酸药物共晶体:两种新型药物-药物共晶体的合成与表征
J Pharm Sci. 2017 May;106(5):1384-1390. doi: 10.1016/j.xphs.2017.01.033. Epub 2017 Feb 7.
2
Pharmaceutical salts of ethionamide with GRAS counter ion donors to enhance the solubility.乙硫异烟胺与一般认为安全(GRAS)的抗衡离子供体形成的药用盐,以提高溶解度。
Eur J Pharm Sci. 2017 Jan 1;96:578-589. doi: 10.1016/j.ejps.2016.10.035. Epub 2016 Nov 1.
3
Insight into Flufenamic Acid Cocrystal Dissolution in the Presence of a Polymer in Solution: from Single Crystal to Powder Dissolution.溶液中聚合物存在下氟芬那酸共晶溶解的研究:从单晶到粉末溶解。
Mol Pharm. 2017 Dec 4;14(12):4583-4596. doi: 10.1021/acs.molpharmaceut.7b00712. Epub 2017 Nov 10.
4
Stabilization of metastable flufenamic acid by inclusion of mefenamic acid: solid solution or epilayer?将甲芬那酸包合稳定亚稳型氟芬那酸:固溶体还是超晶格层?
J Pharm Sci. 2010 Sep;99(9):4013-22. doi: 10.1002/jps.22250.
5
Crystal anisotropy explains structure-mechanics impact on tableting performance of flufenamic acid polymorphs.晶体各向异性解释了结构力学对 flufenamic 酸多晶型物压片性能的影响。
Eur J Pharm Biopharm. 2018 Nov;132:83-92. doi: 10.1016/j.ejpb.2018.09.006. Epub 2018 Sep 10.
6
Additive-induced metastable single crystal of mefenamic acid.添加剂诱导的甲芬那酸亚稳单晶。
Pharm Res. 2006 Oct;23(10):2375-80. doi: 10.1007/s11095-006-9045-y. Epub 2006 Aug 23.
7
Investigating the Influence of Polymers on Supersaturated Flufenamic Acid Cocrystal Solutions.研究聚合物对过饱和氟芬那酸共晶溶液的影响。
Mol Pharm. 2016 Sep 6;13(9):3292-307. doi: 10.1021/acs.molpharmaceut.6b00612. Epub 2016 Aug 15.
8
Pharmaceutical Cocrystals of Ethenzamide: Molecular Structure Analysis Based on Vibrational Spectra and DFT Calculations.乙酰胺的药物共晶:基于振动光谱和 DFT 计算的分子结构分析。
Int J Mol Sci. 2022 Aug 1;23(15):8550. doi: 10.3390/ijms23158550.
9
Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.阿折地平-草酸共晶体和共无定形复合物的固态表征:不同阿折地平多晶型物的影响
J Pharm Biomed Anal. 2017 May 10;138:302-315. doi: 10.1016/j.jpba.2017.02.005. Epub 2017 Feb 4.
10
Quantitative study of solid-state acid-base reactions between polymorphs of flufenamic acid and magnesium oxide using X-ray powder diffraction.采用 X 射线粉末衍射法对 flufenamic 酸多晶型物与氧化镁之间的固-酸碱反应进行定量研究。
J Pharm Biomed Anal. 2010 Mar 11;51(4):866-74. doi: 10.1016/j.jpba.2009.09.021. Epub 2009 Oct 14.

引用本文的文献

1
Investigation of the Spatial Structure of Flufenamic Acid in Supercritical Carbon Dioxide Media via 2D NOESY.通过二维核欧沃豪斯效应光谱法研究氟芬那酸在超临界二氧化碳介质中的空间结构
Materials (Basel). 2023 Feb 11;16(4):1524. doi: 10.3390/ma16041524.
2
Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals.奈韦拉平共晶体的固态表征及溶出度增强
Adv Pharm Bull. 2021 Sep;11(4):772-776. doi: 10.34172/apb.2021.087. Epub 2020 Sep 22.
3
Drug-drug cocrystals: Opportunities and challenges.药物-药物共晶体:机遇与挑战。
Asian J Pharm Sci. 2021 May;16(3):307-317. doi: 10.1016/j.ajps.2020.06.004. Epub 2020 Jul 9.
4
Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs.药物共晶体的挑战与机遇:聚焦于非甾体抗炎药的综述
RSC Med Chem. 2021 Feb 9;12(5):705-721. doi: 10.1039/d0md00400f. eCollection 2021 May 26.
5
A Novel Co-Crystal of Bexarotene and Ligustrazine Improves Pharmacokinetics and Tissue Distribution of Bexarotene in SD Rats.一种新型的贝沙罗汀与川芎嗪共晶改善了贝沙罗汀在SD大鼠体内的药代动力学和组织分布。
Pharmaceutics. 2020 Sep 23;12(10):906. doi: 10.3390/pharmaceutics12100906.